View this student pharmacist session to learn from cell and gene therapy and managed care experts about their impact on healthcare, and other important aspects of these revolutionary medications!
On December 20, 2024, the Centers for Medicare & Medicaid Services (CMS) issued explanations for the maximum fair prices (MFPs) for the drugs selected for the IRA’s Medicare Drug Price Negotiation Program for the initial price applicability year (IPAY) 2026.